Government
A novel receptor-targeted radioactive tracer for intraoperative lymphatic mapping (ILM) — technetium Tc 99m tilmanocept (Lymphoseek, Navidea Biopharmaceuticals) — has been approved by the US Food and Drug Administration (FDA). It is...
Recently became aware of a pathology group in a large community hospital who submitted a retrospective study to look at whole slide imaging versus conventional light microscopy for purposes of primary H&E diagnosis. The goals of the...
The digital edition of CAP Today is available for December. There is an article starting on the first page that reviews thoughts from the FDA Panel meeting on whole slide imaging written by Karen Lusky who has written similar...
The Veterans Affairs Department and Kaiser Permanente have announced a pilot health information exchange project in San Diego to be launched next month that would allow doctors and others at the two organizations to share specific health...
Has effective cancer screening with earlier detection of lower stage disease become too effective with patients disregarding revised screening guidelines. While in screening one casts a wide net to catch as much as possible, there may be...
Meeting announcment abridged from Federal Register Notice. While the time has come and gone for submissions to the panel, the hearings are open to the public. Name of Committee: Hematology and Pathology Devices Panel of the Medical Devices...
